Cullinan Therapeutics Ratios (2020-2023) | CGEM

Ratios Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Profitability
EBT Margin 7.49%
EBIT Margin 7.24%
EBITDA Margin 7.18%
Operating Margin 7.24%
Net Margin 7.49%
FCF Margin -8.00%
Efficiency
Assets Average 347.19M472.01M458.88M445.29M437.32M552.36M642.24M589.18M538.05M518.49M508.35M
Equity Average 335.01M464.12M452.01M435.42M422.42M512.04M595.37M560.58M510.34M492.61M484.20M
Invested Capital 200.31M469.70M458.54M445.47M425.37M419.47M604.62M586.13M535.03M485.65M499.57M468.82M
Asset Utilization Ratio 0.050.040.040.04
Leverage & Solvency
Equity Ratio 0.930.980.990.980.970.960.910.950.950.940.960.95
Valuation
Enterprise Value -208.90M-438.08M-333.71M-676.25M-290.06M-552.87M-868.35M-909.29M-467.29M-659.27M-841.76M-867.98M
Return Ratios
Return on Sales 0.07%-0.79%-1.76%-3.56%
Return on Capital Employed -0.16%-0.24%0.31%0.23%0.26%0.22%-0.33%-0.37%
Return on Invested Capital -0.19%0.21%0.17%0.19%0.11%-0.32%-0.36%
Return on Assets 0.00%-0.03%-0.07%-0.15%-0.19%0.20%0.16%0.19%0.12%-0.27%-0.31%
Return on Equity 0.00%-0.03%-0.07%-0.15%-0.19%0.21%0.17%0.19%0.13%-0.29%-0.32%